PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.51%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-31.58%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-25.81%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-16.73%
Negative net income growth while 0354.HK stands at 8.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-16.72%
Negative EPS growth while 0354.HK is at 0.48%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-16.72%
Negative diluted EPS growth while 0354.HK is at 6.96%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 0354.HK's 4.49%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
-41.69%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-100.83%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-98.73%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-0.74%
Negative 10Y revenue/share CAGR while 0354.HK stands at 436.19%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-0.74%
Negative 5Y CAGR while 0354.HK stands at 93.77%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
27.28%
3Y revenue/share CAGR above 1.5x 0354.HK's 4.65%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-1641.60%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-1641.60%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-512.57%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-41.30%
Negative 10Y net income/share CAGR while 0354.HK is at 134.60%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-41.30%
Negative 5Y net income/share CAGR while 0354.HK is 58.60%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-48.34%
Negative 3Y CAGR while 0354.HK is 320.10%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.67%
Below 50% of 0354.HK's 60.11%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6193.74%
AR growth of 6193.74% while 0354.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
28.40%
Inventory shrinking or stable vs. 0354.HK's 100.55%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-4.51%
Negative asset growth while 0354.HK invests at 7.94%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.85%
Under 50% of 0354.HK's 3.81%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
6.85%
Debt shrinking faster vs. 0354.HK's 31.81%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-17.92%
We cut SG&A while 0354.HK invests at 2.07%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.